
Sign up to save your podcasts
Or


In this episode of the Oncology Brothers podcast, we dive into the groundbreaking data presented at ESMO 2025, focusing on the GU landscape, particularly prostate and bladder cancer. Join us as we welcome Dr. Stephanie Berg, a GU medical oncologist from the Dana-Farber Cancer Institute, to discuss key studies and their implications for patient care.
Episode Highlights:
Stay tuned as we navigate the complexities of treatment options, side effects, and the importance of patient-centered decision-making in oncology.
Follow us on social media:
Don't forget to subscribe for more insights on treatment algorithms, FDA approvals, and conference highlights!
#ESMO2025 #GUOncology #LutetiumPSMA #Enfortumab #BladderCancer #ProstateCancer #OncologyBrothers
By Oncology Brothers4.8
4040 ratings
In this episode of the Oncology Brothers podcast, we dive into the groundbreaking data presented at ESMO 2025, focusing on the GU landscape, particularly prostate and bladder cancer. Join us as we welcome Dr. Stephanie Berg, a GU medical oncologist from the Dana-Farber Cancer Institute, to discuss key studies and their implications for patient care.
Episode Highlights:
Stay tuned as we navigate the complexities of treatment options, side effects, and the importance of patient-centered decision-making in oncology.
Follow us on social media:
Don't forget to subscribe for more insights on treatment algorithms, FDA approvals, and conference highlights!
#ESMO2025 #GUOncology #LutetiumPSMA #Enfortumab #BladderCancer #ProstateCancer #OncologyBrothers

319 Listeners

40 Listeners

118 Listeners

58 Listeners

291 Listeners

2,446 Listeners

3,345 Listeners

1,154 Listeners

198 Listeners

187 Listeners

44 Listeners

22 Listeners

190 Listeners

58 Listeners

189 Listeners